FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors
Today, the FDA approved a novel treatment for hemophilia A or B, with or without factor VIII or IX inhibitors (neutralizing antibodies).
Today, the FDA approved a novel treatment for hemophilia A or B, with or without factor VIII or IX inhibitors (neutralizing antibodies).
Avoid Using or Selling Certain Sacred Tattoo Ink Products
The FDA announced its intent to expand the use of unannounced inspections at foreign manufacturing facilities.
Tempe, AZ, HEALTH FIXER is voluntarily recalling all lots of dietary supplements by the name of Male Ultra, Malextra, Electro Buzz, Ultra Armor and Male…
FOR IMMEDIATE RELEASE – April 28, 2025 – A limited quantity of Trader Joe’s Sesame Miso Salad with Salmon is voluntarily being recalled because the…
JJWV Marketing Corporation of Santa Fe Springs, California is recalling Ankimo Monkfish Liver because it may contain undeclared milk. People who have an allergy or…
The U.S. Department of Health and Human Services and FDA today announced a series of new measures to phase out all petroleum-based synthetic dyes from…
New England Village Foods of Milford NH is recalling all lots of 5 -ounce and 10 -ounce containers of New England Village Snacks “19th Hole…
Mauna Loa Macadamia Nut Company LLC of Kea’au, HI is voluntarily recalling Mauna Loa Dark Chocolate Covered Macadamias (0.6oz and 4oz bags), due to the…
Heart Pump Accessory Removal: Abbott Removes HeartMate Mobile Power Unit due to Instances of Sudden Power Loss
FDA has become aware of reports of adverse events involving compounded topical finasteride products.